Top broker gives its verdict on the Fortescue (ASX:FMG) share price

Here's what a top broker thinks of Fortescue shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fortescue Metals Group Limited (ASX: FMG) share price is trading lower on Tuesday.

At the time of writing, the iron ore giant's shares are down 1% to $21.08.

Female worker sitting desk with head in hand and looking fed up

Image source: Getty Images

Why is the Fortescue share price trading lower?

One thing that could be weighing on the Fortescue share price today is a bearish broker note out of Goldman Sachs.

In response to the company's full year results release, the broker has retained its sell rating and $19.90 price target.

Based on the current Fortescue share price, this implies potential downside of 5.5% over the next 12 months.

Why is Goldman bearish on Fortescue?

According to the note, there are four key reasons why Goldman Sachs doesn't see value in the Fortescue share price at the current level.

One is its valuation in comparison to fellow mining giant Rio Tinto Limited (ASX: RIO). Its analysts note that Fortescue trades at ~1.7x net asset value (NAV) compared to Rio Tinto at ~0.85x NAV.

Another concern the broker has is the widening of low grade 58% iron ore product realisations. Current spot realisations for Fortescue 58% product is at ~75% of the 62% Index versus 84% in the June quarter. It feels that this could worsen as China cuts steel production in the second half of the year.

What else?

Another reason the broker is bearish on the Fortescue is its capital expenditure risks at the Iron Bridge project.

Goldman explained: "Capex has increased to US$3.3-3.5bn (100% basis), c. +US1bn higher since the initial cost when it was approved in April 2019, with a 6-month delay and a slower expected ramp up. We model capex of US$3.7bn and first ore in Q1 2023 (FMG: by Dec 2022), and an 18-24 month ramp up."

Finally, the broker also has concerns over its diversification plans with the Fortescue Future Industries business.

All in all, the Fortescue share price may be down 14% in 2021, but this leading broker feels it can still go lower.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A little girl has a huge smile and a giant lollipop.
Broker Notes

6 ASX shares tipped by brokers to rise 34% to 87%

Post-earnings season, brokers have updated their 12-month price targets on scores of stocks.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

2 ASX shares tipped to return 19% to 47%

Recent sell-offs have caught Morgans’ attention, with the broker now rating both shares as buys.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Buy, hold, sell: Dicker Data, Polynovo, Flight Centre shares

Here's what the experts think.

Read more »

Two scientists analysing results on a computer screen.
Healthcare Shares

3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

After slumping to a 9-year low on 3 June, healthcare shares have rallied by an extraordinary 42%.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

How high could Bubs Australia shares go, according to Bell Potter?

A key approval is expected to boost the Bubs share price.

Read more »

a woman in a business suit looks wide eyed and interested as she holds a tin can with string to hear ear listening to some news.
Broker Notes

UBS names its 10 top ASX picks for the next 3-6 months

Here are the 10 ASX shares UBS thinks could outperform.

Read more »

Happy teen friends jumping in front of a wall.
Broker Notes

Guess which ASX stock could rise 85%

Bell Potter sees significant upside from this stock.

Read more »

Buy the dip written on a yellow sign.
Broker Notes

Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today

A leading expert believes Pro Medicus shares are well-place to rebound.

Read more »